vimarsana.com

Latest Breaking News On - Bi sky global ltd - Page 1 : vimarsana.com

CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6 8M Mark - InnoCan Pharma (OTC:INNPF)

Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.

Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6 8 Million

/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on.

Innocan Pharma Corporation: Innocan Pharma Reports First Quarter 2024 Results with Revenue Growth of over 4X to $6 8 Million

HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.